ALB vs NERV · rev $1.74B vs P/E 2.2, $12.4M cap
Albemarle Corp (ALB) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
NERV does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the ALB and NERV stock pages for the full models.
Not investment advice.